The Role of Basic Fibroblast Growth Factor in Human Breast Cancer
Abstract
We have demonstrated that recombinant basic fibroblast growth factor (bFGF) inhibits proliferation and promotes programmed cell death in MCF-7 and a number of other breast cancer cells. These effects are opposite of the effects seen in fibroblasts. Since bFGF acts as a key angiogenesis factor in breast cancer and the bFGF content of breast cancer cells diminishes as they progress toward an ever more malignant phenotype, we investigated the effects of overexpressing bFGF in MCF-7 cells on the survival of these cells following treatment with two chemotherapeutic agents, etoposide and 5-fluorouracil. We contrasted these finding with data obtained in NIH 3T3 fibroblasts also transduced with bFGF.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 1997
- Accession Number
- ADA335806
Entities
People
- Robert Wieder